Italfarmaco Inofert dietary supplement with Inositol and Folic acid 30sachets

Inofert is a dietary supplement with inositol and folic acid, which has been developed specifically for the regulation of ovarian function. Inofert is a handy and effective supplement for improving metabolic and hormonal profile of women with Polycystic Ovary Syndrome. Inofert can also be added as an adjuvant on protocols of controlled ovarian hyperstimulation. Inofert is available is in packs of 30 sachets , each of which contains 2 grams of inositol and 200 micrograms of folic acid. Inofert can be taken at any time of the day , dissolved in a glass of water. Inofert contains no sucrose , lactose or gluten.

About inositol : Inositol is considered by most researchers as a factor of vitamin B. In scientific terms , the inositol is a compound called carbocyclic polyalcohol , of which the most important form in nature is myo-inositol. Other forms ( isomers ) present in nature are : scyllo-, L-chiro, D-chiro-muco-, neo-, allo-, epi-, cis- inositol . Inositol is a sugar, but cyclic alcohol. Inositol is actively synthesized within the human body and the quantity is much greater than that ingested in the diet. The two tissues that appear to be primarily involved in the liver and kidneys .Like other vitamins of group B, inositol is water soluble, why a potential recruit in pure form does not cause intolerance or toxicity.

Inositol can intervene positively: In the structure of cell membranes. The control of the metabolism of fats and sugars.

Increased hair. In checking the function of nerve cells • In the process of cell growth , fertilization and excretion. A diet low in Inositol may increase cholesterol , triglycerides , lipid accumulation in the liver ( hepatic steatosis ) and reduce inositol levels in all tissues .A diet deficient in inositol during pregnancy and lactation leads to low levels of inositol in the tissues of the newborn and in breast milk and elevated levels of lipids in the liver of the mother.

SOURCES OF INOSITOL Inositol is widespread in animals where it forms various phospholipids and plant organisms which is present in the form of folate. The vegetative form of the inositol contained in many plants used as foodstuffs and represents 75 % of the total phosphorus present in cereal grains .

The richest dietary sources of inositol are: Bran Citrus fruits ( except lemons ) Cereal grains whole grain oat lecithin granules Melon Lentils Beans Pork Dried beans Walnuts Beef liver Chickpea Rice • Beef Inositol and PCOSPCOS is the most common cause of chronic anovulatory infertility due to fertile women .Inositol has a positive effect on ovarian function ( price reduction of androgens in serum, plasma triglyceride , blood pressure , insulin levels ) and the restoration of a normal ovarian cycle with better maturation of oocytes .Also, inositol supplementation , due to its ability to increase insulin sensitivity , helps to improve the quality of oocytes and the increase in the number of oocytes collected after ovarian stimulation in patients who undergo an Assisted Reproduction.

According to scientific studies that have been conducted so far, the treatment of PCOS with inositol provide : Improve ovarian function. Improving hyperinsulinemia. Improving the hormonal profile. Reduction of peripheral effects of androgens• No consequential effect Apart from the treatment of PCOS , has ascertained that the inositol and provides benefits in the following areas : In the prevention of neural tube defects in combination with folic acid. In regulating lipid metabolism and reduce cholesterol in the blood. The improvement of nerve conduction in diabetics, with a significant reduction of symptomsIn the treatment of obsessive compulsive disorder • In the treatment of anxiety and insomnia due to anxiolytic action.

Bibliography - Symposium " Innovations in Obstetrics and Gynecology " , March 2011, Ferrara, L'inositolo (D. Costantino) and L'inositolo nella terapia della PCOS (G. Dante, F. Facchinetti) - Effetti dell'inositolo sulla qualità ovocitaria in pazienti affette da sindrome dell'ovaio policistico, M. Stracquadanio et al., Riv. It. Ost. Gin. - 2010 - No. 27.

30 sachets.